Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 237

1.

Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen.

Zamith-Miranda D, Heyman HM, Cleare LG, Couvillion SP, Clair GC, Bredeweg EL, Gacser A, Nimrichter L, Nakayasu ES, Nosanchuk JD.

mSystems. 2019 Jun 11;4(4). pii: e00257-19. doi: 10.1128/mSystems.00257-19.

2.

Anti-biofilm activity of garlic extract loaded nanoparticles.

Girish VM, Liang H, Aguilan JT, Nosanchuk JD, Friedman JM, Nacharaju P.

Nanomedicine. 2019 May 11;20:102009. doi: 10.1016/j.nano.2019.04.012. [Epub ahead of print]

PMID:
31085344
3.

Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin.

Krausz AE, Adler BL, Makdisi J, Schairer D, Rosen J, Landriscina A, Navati M, Alfieri A, Friedman JM, Nosanchuk JD, Rodriguez-Gabin A, Ye KQ, McDaid HM, Friedman AJ.

Precis Nanomed. 2018 Oct;1(3):173-182. doi: 10.33218/prnano1(3).181029.1. Epub 2018 Oct 27.

4.

Extracellular Vesicle-Mediated RNA Release in Histoplasma capsulatum.

Alves LR, Peres da Silva R, Sanchez DA, Zamith-Miranda D, Rodrigues ML, Goldenberg S, Puccia R, Nosanchuk JD.

mSphere. 2019 Mar 27;4(2). pii: e00176-19. doi: 10.1128/mSphere.00176-19.

5.

Fidgetin-Like 2 siRNA Enhances the Wound Healing Capability of a Surfactant Polymer Dressing.

O'Rourke BP, Kramer AH, Cao LL, Inayathullah M, Guzik H, Rajadas J, Nosanchuk JD, Sharp DJ.

Adv Wound Care (New Rochelle). 2019 Mar 1;8(3):91-100. doi: 10.1089/wound.2018.0827. Epub 2019 Mar 5.

6.

Candida parapsilosis: from Genes to the Bedside.

Tóth R, Nosek J, Mora-Montes HM, Gabaldon T, Bliss JM, Nosanchuk JD, Turner SA, Butler G, Vágvölgyi C, Gácser A.

Clin Microbiol Rev. 2019 Feb 27;32(2). pii: e00111-18. doi: 10.1128/CMR.00111-18. Print 2019 Mar 20. Review.

PMID:
30814115
7.

Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance.

Papp C, Kocsis K, Tóth R, Bodai L, Willis JR, Ksiezopolska E, Lozoya-Pérez NE, Vágvölgyi C, Mora Montes H, Gabaldón T, Nosanchuk JD, Gácser A.

mSphere. 2018 Nov 14;3(6). pii: e00547-18. doi: 10.1128/mSphere.00547-18.

8.

Host membrane glycosphingolipids and lipid microdomains facilitate Histoplasma capsulatum internalisation by macrophages.

Guimarães AJ, de Cerqueira MD, Zamith-Miranda D, Lopez PH, Rodrigues ML, Pontes B, Viana NB, DeLeon-Rodriguez CM, Rossi DCP, Casadevall A, Gomes AMO, Martinez LR, Schnaar RL, Nosanchuk JD, Nimrichter L.

Cell Microbiol. 2019 Mar;21(3):e12976. doi: 10.1111/cmi.12976. Epub 2018 Dec 7.

PMID:
30427108
9.

Paracoccidioides spp. and Histoplasma capsulatum: Current and New Perspectives for Diagnosis and Treatment.

Taborda CP, Buccheri R, Benard G, Duarte-Neto AN, Nosanchuk JD, Travassos LR.

Curr Top Med Chem. 2018;18(15):1333-1348. doi: 10.2174/1568026618666181002112231. Review.

PMID:
30277157
10.

Nitric oxide-releasing microparticles as a potent antimicrobial therapeutic against chronic rhinosinusitis bacterial isolates.

Abuzeid WM, Girish VM, Fastenberg JH, Draganski AR, Lee AY, Nosanchuk JD, Friedman JM.

Int Forum Allergy Rhinol. 2018 Oct;8(10):1190-1198. doi: 10.1002/alr.22185. Epub 2018 Jul 25.

PMID:
30044542
11.

Histoplasma Capsulatum: Mechanisms for Pathogenesis.

Mittal J, Ponce MG, Gendlina I, Nosanchuk JD.

Curr Top Microbiol Immunol. 2018 Jul 25. doi: 10.1007/82_2018_114. [Epub ahead of print]

PMID:
30043340
12.

Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments.

Costa-Orlandi CB, Mordorski B, Baltazar LM, Mendes-Giannini MJS, Friedman JM, Nosanchuk JD, Friedman AJ.

J Drugs Dermatol. 2018 Jul 1;17(7):717-720.

PMID:
30005092
13.

Concentration-dependent protein loading of extracellular vesicles released by Histoplasma capsulatum after antibody treatment and its modulatory action upon macrophages.

Baltazar LM, Zamith-Miranda D, Burnet MC, Choi H, Nimrichter L, Nakayasu ES, Nosanchuk JD.

Sci Rep. 2018 May 23;8(1):8065. doi: 10.1038/s41598-018-25665-5.

14.

Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei.

Pruksaphon K, Intaramat A, Ratanabanangkoon K, Nosanchuk JD, Vanittanakom N, Youngchim S.

PLoS One. 2018 Apr 11;13(4):e0195596. doi: 10.1371/journal.pone.0195596. eCollection 2018.

15.

Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy.

Nosanchuk JD, Jeyakumar A, Ray A, Revskaya E, Jiang Z, Bryan RA, Allen KJH, Jiao R, Malo ME, Gómez BL, Morgenstern A, Bruchertseifer F, Rickles D, Thornton GB, Bowen A, Casadevall A, Dadachova E.

Sci Rep. 2018 Apr 3;8(1):5466. doi: 10.1038/s41598-018-23889-z.

16.

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds.

de-Souza-Silva CM, Guilhelmelli F, Zamith-Miranda D, de Oliveira MA, Nosanchuk JD, Silva-Pereira I, Albuquerque P.

J Vis Exp. 2018 Feb 14;(132). doi: 10.3791/57127.

PMID:
29553507
17.

Fungal extracellular vesicles: modulating host-pathogen interactions by both the fungus and the host.

Zamith-Miranda D, Nimrichter L, Rodrigues ML, Nosanchuk JD.

Microbes Infect. 2018 Oct - Nov;20(9-10):501-504. doi: 10.1016/j.micinf.2018.01.011. Epub 2018 Feb 19.

PMID:
29471026
18.

Investigation of Candida parapsilosis virulence regulatory factors during host-pathogen interaction.

Tóth R, Cabral V, Thuer E, Bohner F, Németh T, Papp C, Nimrichter L, Molnár G, Vágvölgyi C, Gabaldón T, Nosanchuk JD, Gácser A.

Sci Rep. 2018 Jan 22;8(1):1346. doi: 10.1038/s41598-018-19453-4.

19.

The putative flippase Apt1 is required for intracellular membrane architecture and biosynthesis of polysaccharide and lipids in Cryptococcus neoformans.

Rizzo J, Colombo AC, Zamith-Miranda D, Silva VKA, Allegood JC, Casadevall A, Del Poeta M, Nosanchuk JD, Kronstad JW, Rodrigues ML.

Biochim Biophys Acta Mol Cell Res. 2018 Mar;1865(3):532-541. doi: 10.1016/j.bbamcr.2017.12.007. Epub 2017 Dec 29.

20.

Intracellular Eukaryotic Pathogens' Virulence Attributes and Their Interplay with Host Immune Defenses.

Bocca AL, de Almeida Soares CM, Nosanchuk JD, Silva-Pereira I.

Mediators Inflamm. 2017;2017:1264974. doi: 10.1155/2017/1264974. Epub 2017 Nov 5. No abstract available.

21.

L-tyrosine induces the production of a pyomelanin-like pigment by the parasitic yeast-form of Histoplasma capsulatum.

Almeida-Paes R, Almeida-Silva F, Pinto GCM, Almeida MA, Muniz MM, Pizzini CV, Gerfen GJ, Nosanchuk JD, Zancopé-Oliveira RM.

Med Mycol. 2018 Jun 1;56(4):506-509. doi: 10.1093/mmy/myx068.

22.

Editorial: Vaccines, Immunotherapy and New Antifungal Therapy against Fungi: Updates in the New Frontier.

Taborda CP, Nosanchuk JD.

Front Microbiol. 2017 Sep 8;8:1743. doi: 10.3389/fmicb.2017.01743. eCollection 2017. No abstract available.

23.

Characterization of the antifungal functions of a WGA-Fc (IgG2a) fusion protein binding to cell wall chitin oligomers.

Liedke SC, Miranda DZ, Gomes KX, Gonçalves JLS, Frases S, Nosanchuk JD, Rodrigues ML, Nimrichter L, Peralta JM, Guimarães AJ.

Sci Rep. 2017 Sep 22;7(1):12187. doi: 10.1038/s41598-017-12540-y.

24.

Heat Shock Proteins in Histoplasma and Paracoccidioides.

Cleare LG, Zamith-Miranda D, Nosanchuk JD.

Clin Vaccine Immunol. 2017 Nov 6;24(11). pii: e00221-17. doi: 10.1128/CVI.00221-17. Print 2017 Nov. Review.

25.

Development and Evaluation of a Web-Based Dermatology Teaching Tool for Preclinical Medical Students.

Scaperotti M, Gil N, Downs I, Jeyakumar A, Liu A, Chan J, Bonner J, Kelly MS, Nosanchuk JD, Cohen HW, Jerschow E.

MedEdPORTAL. 2017 Aug 12;13:10619. doi: 10.15766/mep_2374-8265.10619.

26.

Topical nitric oxide releasing nanoparticles are effective in a murine model of dermal Trichophyton rubrum dermatophytosis.

Mordorski B, Costa-Orlandi CB, Baltazar LM, Carreño LJ, Landriscina A, Rosen J, Navati M, Mendes-Giannini MJS, Friedman JM, Nosanchuk JD, Friedman AJ.

Nanomedicine. 2017 Oct;13(7):2267-2270. doi: 10.1016/j.nano.2017.06.018. Epub 2017 Jul 13.

PMID:
28712918
27.

Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis.

Silva LBR, Dias LS, Rittner GMG, Muñoz JE, Souza ACO, Nosanchuk JD, Travassos LR, Taborda CP.

Front Microbiol. 2017 Jun 14;8:1057. doi: 10.3389/fmicb.2017.01057. eCollection 2017.

28.

Melanization of Fusarium keratoplasticum (F. solani Species Complex) During Disseminated Fusariosis in a Patient with Acute Leukemia.

Chiewchanvit S, Chongkae S, Mahanupab P, Nosanchuk JD, Pornsuwan S, Vanittanakom N, Youngchim S.

Mycopathologia. 2017 Oct;182(9-10):879-885. doi: 10.1007/s11046-017-0156-2. Epub 2017 Jun 14.

PMID:
28616680
29.

Analysis of multiple components involved in the interaction between Cryptococcus neoformans and Acanthamoeba castellanii.

Rizzo J, Albuquerque PC, Wolf JM, Nascimento R, Pereira MD, Nosanchuk JD, Rodrigues ML.

Fungal Biol. 2017 Jun - Jul;121(6-7):602-614. doi: 10.1016/j.funbio.2017.04.002. Epub 2017 Apr 20.

PMID:
28606355
30.

Miltefosine is fungicidal to Paracoccidioides spp. yeast cells but subinhibitory concentrations induce melanisation.

Rossi DCP, Spadari CC, Nosanchuk JD, Taborda CP, Ishida K.

Int J Antimicrob Agents. 2017 Apr;49(4):465-471. doi: 10.1016/j.ijantimicag.2016.12.020. Epub 2017 Mar 6.

PMID:
28279786
31.

Ketoconazole inhibits Malassezia furfur morphogenesis in vitro under filamentation optimized conditions.

Youngchim S, Nosanchuk JD, Chongkae S, Vanittanokom N.

Arch Dermatol Res. 2017 Jan;309(1):47-53. doi: 10.1007/s00403-016-1701-4. Epub 2016 Nov 24.

PMID:
27885419
32.

Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.

Mihu MR, Cabral V, Pattabhi R, Tar MT, Davies KP, Friedman AJ, Martinez LR, Nosanchuk JD.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e02020-16. doi: 10.1128/AAC.02020-16. Print 2017 Jan.

33.

Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.

Aguilar JL, Varshney AK, Pechuan X, Dutta K, Nosanchuk JD, Fries BC.

Virulence. 2017 Aug 18;8(6):741-750. doi: 10.1080/21505594.2016.1231295. Epub 2016 Oct 7.

34.

Targeting Microtubules for Wound Repair.

Charafeddine RA, Nosanchuk JD, Sharp DJ.

Adv Wound Care (New Rochelle). 2016 Oct 1;5(10):444-454. Review.

35.

Extracellular Vesicle-Associated Transitory Cell Wall Components and Their Impact on the Interaction of Fungi with Host Cells.

Nimrichter L, de Souza MM, Del Poeta M, Nosanchuk JD, Joffe L, Tavares Pde M, Rodrigues ML.

Front Microbiol. 2016 Jul 8;7:1034. doi: 10.3389/fmicb.2016.01034. eCollection 2016. Review.

36.

Butyricimonas virosa bacteraemia and bowel disease: case report and review.

Enemchukwu CU, Ben-Faras H, Gialanella P, Szymczak WA, Nosanchuk JD, Madaline TF.

New Microbes New Infect. 2016 May 14;13:34-6. doi: 10.1016/j.nmni.2016.05.004. eCollection 2016 Sep.

37.

Antibody Binding Alters the Characteristics and Contents of Extracellular Vesicles Released by Histoplasma capsulatum.

Matos Baltazar L, Nakayasu ES, Sobreira TJ, Choi H, Casadevall A, Nimrichter L, Nosanchuk JD.

mSphere. 2016 Mar 30;1(2). pii: e00085-15. doi: 10.1128/mSphere.00085-15. eCollection 2016 Mar-Apr.

38.

Talaromyces marneffei laccase modifies THP-1 macrophage responses.

Sapmak A, Kaewmalakul J, Nosanchuk JD, Vanittanakom N, Andrianopoulos A, Pruksaphon K, Youngchim S.

Virulence. 2016 Aug 17;7(6):702-17. doi: 10.1080/21505594.2016.1193275. Epub 2016 May 25.

39.

Role of Protein Glycosylation in Candida parapsilosis Cell Wall Integrity and Host Interaction.

Pérez-García LA, Csonka K, Flores-Carreón A, Estrada-Mata E, Mellado-Mojica E, Németh T, López-Ramírez LA, Toth R, López MG, Vizler C, Marton A, Tóth A, Nosanchuk JD, Gácser A, Mora-Montes HM.

Front Microbiol. 2016 Mar 8;7:306. doi: 10.3389/fmicb.2016.00306. eCollection 2016.

40.

Enhanced virulence of Histoplasma capsulatum through transfer and surface incorporation of glycans from Cryptococcus neoformans during co-infection.

Cordero RJ, Liedke SC, de S Araújo GR, Martinez LR, Nimrichter L, Frases S, Peralta JM, Casadevall A, Rodrigues ML, Nosanchuk JD, Guimaraes AJ.

Sci Rep. 2016 Feb 24;6:21765. doi: 10.1038/srep21765.

41.

Antibodies Against Glycolipids Enhance Antifungal Activity of Macrophages and Reduce Fungal Burden After Infection with Paracoccidioides brasiliensis.

Bueno RA, Thomaz L, Muñoz JE, da Silva CJ, Nosanchuk JD, Pinto MR, Travassos LR, Taborda CP.

Front Microbiol. 2016 Feb 3;7:74. doi: 10.3389/fmicb.2016.00074. eCollection 2016.

42.

A novel inhibition ELISA for the detection and monitoring of Penicillium marneffei antigen in human serum.

Prakit K, Nosanchuk JD, Pruksaphon K, Vanittanakom N, Youngchim S.

Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):647-56. doi: 10.1007/s10096-016-2583-2. Epub 2016 Feb 2.

PMID:
26838686
43.

Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.

Ahmadi MS, Lee HH, Sanchez DA, Friedman AJ, Tar MT, Davies KP, Nosanchuk JD, Martinez LR.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2185-94. doi: 10.1128/AAC.02659-15. Print 2016 Apr.

44.

Effects of silencing 14-3-3 protein in Paracoccidiodes brasiliensis infection.

Garcia-Rodas R, Nosanchuk JD.

Virulence. 2016;7(2):68-9. doi: 10.1080/21505594.2015.1137423. Epub 2016 Jan 11. No abstract available.

45.

Fungal Melanin: What do We Know About Structure?

Nosanchuk JD, Stark RE, Casadevall A.

Front Microbiol. 2015 Dec 22;6:1463. doi: 10.3389/fmicb.2015.01463. eCollection 2015. Review.

46.

The Einstein-Brazil Fogarty: A decade of synergy.

Nosanchuk JD, Nosanchuk MD, Rodrigues ML, Nimrichter L, Carvalho AC, Weiss LM, Spray DC, Tanowitz HB.

Braz J Microbiol. 2015 Oct-Dec;46(4):945-55. doi: 10.1590/S1517-838246420140975. Review.

47.

Bensal HP Treatment for Burn and Excision Wounds: An In-Vivo Assessment of Wound Healing Efficacy and Immunological Impact.

Rosen J, Landriscina A, Ray A, Tesfa L, Nosanchuk JD, Friedman AJ.

J Drugs Dermatol. 2015 Nov;14(11):1322-6.

PMID:
26580882
48.

Methamphetamine Alters the Antimicrobial Efficacy of Phagocytic Cells during Methicillin-Resistant Staphylococcus aureus Skin Infection.

Mihu MR, Roman-Sosa J, Varshney AK, Eugenin EA, Shah BP, Ham Lee H, Nguyen LN, Guimaraes AJ, Fries BC, Nosanchuk JD, Martinez LR.

MBio. 2015 Oct 27;6(6):e01622-15. doi: 10.1128/mBio.01622-15.

49.

PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS.

Taborda CP, Urán ME, Nosanchuk JD, Travassos LR.

Rev Inst Med Trop Sao Paulo. 2015 Sep;57 Suppl 19:21-4. doi: 10.1590/S0036-46652015000700005. Review.

50.

Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response.

Qin M, Landriscina A, Rosen JM, Wei G, Kao S, Olcott W, Agak GW, Paz KB, Bonventre J, Clendaniel A, Harper S, Adler BL, Krausz AE, Friedman JM, Nosanchuk JD, Kim J, Friedman AJ.

J Invest Dermatol. 2015 Nov;135(11):2723-2731. doi: 10.1038/jid.2015.277. Epub 2015 Jul 14.

Supplemental Content

Loading ...
Support Center